This morning H1, an artificial intelligence healthcare data insights company, announced that it raised $6 million in funding from its incubator Shore Group. The new money is expected to help the New York-based company speed up its growth and development.

H1’s platform combines public clinical and scholarly databases with AI with the goal of helping healthcare professionals with targeted databases. According to the company’s website, the platform was built on more than fifty million journal articles, 250,000 clinical trials and input form 750,000 clinicians and doctors. 

Currently the company has three main platforms — all named after notable scientists and innovators. The first, H1 Ada, can give companies records of individuals and organizations in the medical field. The second is the H1 Curie, which gives users a list of thought leaders and their accomplishments. It will also give users the subject’s contact information and workplace. The most recent tool is called the H1 DaVinci, which helps users with strategic planning. 

Why it matters

Data has grown increasingly important in the healthcare sector, but organizing and finding relevant data points has been a challenge for providers and life science professionals. 

“H1 has been very successful in developing technology that surfaces hard-to-find healthcare data, and arms clients with that data so they can make better and faster data-driven decisions along their development pipeline,” Ian Sax, CEO of Shore Group, said in a statement. 

The trend

H1 isn’t the only company taking advantage of artificial intelligence to help companies with insights. In September AI-enabled healthcare insights company Clarify Health Solutions announced that it closed a $57 million Series B financing round led by global firm KKR. However, this company has a different model than H1 — it provides predictive analytics and machine learning to the care delivery model.  

On the record 

“With expertise in data collection for some of the largest global financial institutions, Shore Group was the ideal incubation spot for H1, as we established ourselves in the healthcare data space,” Ariel Katz, cofounder of H1, said in a statement. “Now that we are on solid footing, with a clear path to growth, we’re excited to operate independently, with Shore Group’s backing as an investor.”